Daejin Abidoye, M.D.
Vice President, Therapeutic Area Head, Oncology, Solid Tumor and Hematology
Dr. Daejin Abidoye serves as Vice President, Therapeutic Area Head, Oncology, Solid Tumor and Hematology at AbbVie. In this role, he is responsible for the clinical development of all assets in late oncology clinical development.
Dr. Abidoye’s career includes over 20 years of experience in oncology, cancer research and drug development. Prior to joining AbbVie, Dr. Abidoye was the Therapeutic Area Lead for Oncology Development and Clinical Research at Gilead Sciences. He has also held various roles at Seattle Genetics and Roche-Genentech. Dr. Abidoye is a board-certified oncologist with a career in clinical practice at Scripps Health in Southern California.
Dr. Abidoye completed his residency in internal medicine at St. Elizabeth’s Medical Center in Boston and his fellowship training in hematology and oncology at the University of Chicago. He received his M.D. from the University of Lagos in Nigeria and his M.P.H. degree in Clinical Research from Temple University in Philadelphia.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2026 AbbVie Inc. North Chicago, Illinois, U.S.A.
